Announced
Completed
Synopsis
ICON, a provider of drug and device development and commercialization services to the pharmaceutical industry, completed the acquisition of MedPass International, a medical device CRO and regulatory and reimbursement consultancy. Financial terms were not disclosed. “As the leader in Medical Device Regulation and Clinical Development in Europe, MedPass is delighted to be joining ICON to become the global service provider of choice in Medtech Devices and Diagnostics,” Sarah Sorrell, MedPass President and CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.